From the Williston (NDak) Herald News Daily:
Federal health officials are stopping short of recommending genetic tests for patients on the blood-thinner warfarin, even though they have said such screenings could prevent thousands of complications each year.
"This means personalized medicine is no longer an abstract concept but has moved into the mainstream," the Food and Drug Administration‘s clinical pharmacology chief, Larry Lesko, said in announcing the label change.
The FDA has not changed its dosing recommendations for the drug, and tailoring the proper dosage remains largely a matter of trial and error.
Genetic testing can reveal which patients may require less of the drug and lead doctors to recommend doses closer to the lower end of the scale, FDA officials said. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment